Affymax (AFFY)
Affymax Expenses: 31.76M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
AFFY Expenses Rankings
| Overall | 28th percentile | 3159 of 4424 |
| Sector | 49th percentile | 239 of 470 in Healthcare |
| Industry | 66th percentile | 44 of 132 in Biotechnology |
AFFY Expenses Range, Past 5 Years
| Minimum | 18.23M | Dec 2010 |
| Maximum | 51.16M | Dec 2008 |
| Average | 35.06M |
About Expenses
Any cost incurred by a business for revenue generating activities.
YCharts calculates this number as Total Revenues - Net Income.
Learn More
You may also be interested in these AFFY related companies
AFFY News
$AFFY I think we see a consolidation at 14, lets see if it can break free from 14 for good next week. Out for now looking for an entry.
about 2 days ago by mydanilo
about 2 days ago by mydanilo
$AFFY http://stks.co/3w3g on watch list and now at the line - volume 17% of average full day
about 5 days ago by StockTiger
about 5 days ago by StockTiger
Streetinsider.com's Hot Lunchtime Reads 05/21: (AAPL) (FB) (LVS) (AFFY) (GDP)
May 21, 12:35PM Street Insider
May 21, 12:35PM Street Insider
$AFFY Not a dead cat bounce today. Continuation of uptrend. This stock was almost at $15 last week before the market got nasty.
about 6 days ago by chileeater
about 6 days ago by chileeater
Analyst Sees Affymax's (AFFY) Omontys as Comparable to Amgen's (AMGN) Epogen; Raises AFFY Target to $21
May 21, 12:17PM Street Insider
May 21, 12:17PM Street Insider
$AFFY http://stks.co/3r6w was out this AM but see this watch list stock hit trigger and doing ok so far
about 11 days ago by StockTiger
about 11 days ago by StockTiger
Market Wrap Video + Additions to Watch List http://stks.co/3qQd including: $FFN $LLNW $AFFY $GET $DHI $CTSH $SREV
about 11 days ago by StockTiger
about 11 days ago by StockTiger
RT @mydanilo $AFFY at previous high from March, going to be interesting __ It is going interestingly!
about 12 days ago by Glopolon
about 12 days ago by Glopolon
Auriga Maintains a 'Buy' on Affymax, Inc. (AFFY); Milestone Payments Drive Q1 Upside; Continue Seeing Market Opp for Omontys
May 08, 10:42AM Street Insider
May 08, 10:42AM Street Insider
Affymax Announces First Quarter 2012 Financial Results Teleconference and Webcast
Apr 30, 4:00PM Business Wire
Apr 30, 4:00PM Business Wire
Affymax (AFFY), Takeda Announce CMS Assigned Q-Code for OMONTYS(R) Injection
Apr 13, 8:06AM Street Insider
Apr 13, 8:06AM Street Insider
Affymax, Inc. (AFFY) Received $50 Million Milestone Payment From Takeda Pharmaceutical
Apr 09, 4:01PM Street Insider
Apr 09, 4:01PM Street Insider
Affymax Receives a $50M Milestone Payment for U.S. Approval of OMONTYS Injection
Apr 09, 4:00PM Benzinga
Apr 09, 4:00PM Benzinga
Affymax Receives a $50 Million Milestone Payment for U.S. Approval of OMONTYS® (peginesatide) Injection
Apr 09, 4:00PM Business Wire
Apr 09, 4:00PM Business Wire
Visium Asset Management, LP Shows New 9.13% Stake in Affymax, Inc. (AFFY)
Apr 05, 4:20PM Street Insider
Apr 05, 4:20PM Street Insider
Affymax Analyst: Company Moving Higher on Momentum, Stock is Still Undervalued Here
Apr 05, 2:00PM Benzinga
Apr 05, 2:00PM Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AFFY | 14.07 | -0.18 | -1.26% | 503.28M |
| AFFX | 4.96 | +0.03 | +0.61% | 349.43M |
| AFFM | 0.4502 | -0.10 | -18.10% | 6.938M |
| AGO | 12.23 | -0.11 | -0.89% | 2.233B |
| AGNC | 32.22 | +0.09 | +0.28% | 9.666B |
| AGN | 90.53 | +0.04 | +0.04% | 27.59B |
| AGMA | 18.51 | +0.00 | +0.00% | |
| AGM | 24.44 | +0.11 | +0.45% | 253.20M |
| AGII | 28.82 | +0.77 | +2.75% | 753.64M |
| AGG | 110.92 | +0.17 | +0.15% |
